An easy way to put it, is that L-Carnitine helps transport fatty acids to be utilized as energy
Independent laboratories test using standardized protocols that meet industry benchmarks for peptide characterization
While early-generation nanomedicines (such as liposomal mifamurtide) have historical clinical applications in osteosarcoma, and some nanocarriers like epirubicin micelles (NC-6300) have entered early-phase trials for general sarcomas, none of the advanced, multi-targeted nanomedicine-immunotherapy combination platforms discussed in this review have yet entered active clinical trials specifically for osteosarcoma
They vary by manufacturer, dose, how they are taken and approved use
Further details of the clinical trial protocols, study populations, statistical analysis plans, and study outcomes have been published [25, 26]